Understanding How Lungs Mature and Prevent Breathing Problems
Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation
This research helps us understand how lung cells develop and produce a vital substance called surfactant, which is crucial for healthy breathing in both babies and adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11159525 on NIH RePORTER |
What this research studies
Our lungs need a special substance called surfactant to stay open and work properly, preventing conditions like respiratory distress. This project looks at specific proteins, PRDM3 and PRDM16, that act like switches, controlling how lung cells mature and produce this important surfactant. We want to learn how these switches open up the genetic instructions within lung cells, allowing them to develop correctly before birth and repair themselves after injury. By understanding these fundamental processes, we hope to find new ways to help lungs function better.
Who could benefit from this research
Good fit: This foundational research is relevant for individuals affected by or at risk of acute lung injury, acute respiratory distress syndrome, or neonatal respiratory distress syndrome.
Not a fit: Patients whose lung conditions are unrelated to surfactant production or alveolar maturation may not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent or treat severe breathing problems like Acute Respiratory Distress Syndrome (ARDS) in adults and respiratory distress in newborns.
How similar studies have performed: While the specific role of PRDM3/16 in chromatin accessibility for alveolar maturation is novel, other studies have successfully identified genes and regulators important for surfactant production and lung development.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Whitsett, Jeffrey a — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Whitsett, Jeffrey a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.